Habibullah Jamal, MD
Otolaryngology · Rye Brook, NYNPI 1427137785
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $177,346 of the $178,624 with a category attached, or 99.3%. Cephea Valve Technologies, Inc. accounts for 99.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $156,879 and has fallen 100.0% since, to $54 in 2023. Among otolaryngology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 13 payments — averaging $13,740 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cephea Valve Technologies, Inc.$177K
- KARL Storz Endoscopy-america$1K
- Optinose US, Inc.$80
- GSK$30
- Hikma Pharmaceuticals USA$23
- Intersect ENT, Inc.$23
- plus $48 from 3 others
What the payments were for
- Food & beverage$2030%
- Gifts$1,0751%
- Ownership interest$177,34699%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cephea Valve Technologies, Inc. | 2 | $177,346 |
| KARL Storz Endoscopy-america | 1 | $1,075 |
| Optinose US, Inc. | 4 | $80 |
| GSK | 1 | $30 |
| Hikma Pharmaceuticals USA | 1 | $23 |
| Intersect ENT, Inc. | 1 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Glenmark Therapeutics Inc. | 1 | $16 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$178,624 in reported general payments places this provider in the 95th percentile of 701 otolaryngology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 102 | $2,938 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 23 | $2,607 |
| Azelastine Hcl | 103 | $2,511 |
| Fluticasone Propionate | 126 | $1,452 |
| Fluocinolone Acetonide Oil | 29 | $1,368 |
| Ofloxacin | 21 | $993 |
| Pantoprazole Sodium | 15 | $352 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $344 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $300 |
| Doxycycline Hyclate | 25 | $299 |
| Mupirocin | 11 | $147 |
| Triamcinolone Acetonide | 21 | $91 |
| Azithromycin | 11 | $54 |
| Prednisone | 16 | $53 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Rye Brook
- Robert KellmanSyracuse$2.5M
- Roheen RaithathaNew York$830K
- Nora PerkinsAlbany$300K
- Moshe EphratNew Hyde Park$250K
- Gavin SetzenAlbany$243K
- Albert JenFlushing$171K
- Dennis KrausNew York$159K
- Nitin BhatiaWhite Plains$120K
- Sveta KarelskyRochester$101K
- Anthony DelsignoreNew York$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.